Susan M. OBrien, MD The University of California, Irvine Medical Center

Articles by Susan M. OBrien, MD The University of California, Irvine Medical Center

Latest Updated Articles

Trending on OncLive

Durvalumab Plus Enfortumab Vedotin Improves Survival in Cisplatin-Ineligible MIBC

Adjuvant Intismeran Autogene Plus Pembrolizumab Improves RFS and DMFS in Melanoma

Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves ctDNA Clearance in Cisplatin-Eligible MIBC

Atirmociclib Plus Fulvestrant Improves PFS in HR+/HER2– Advanced Breast Cancer

DASL-HiCaP: Darolutamide Plus ADT and Radiation Therapy Improves MFS in Very High-Risk Localized Prostate Cancer